Envista Holdings Corporation header image

Envista Holdings Corporation

NVST

Equity

ISIN US29415F1049 / Valor 49153522

New York Stock Exchange, Inc (2024-11-21)
USD 21.39+5.01%

Envista Holdings Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Envista Holdings Corporation is a global company that develops and manufactures a wide range of dental products, equipment, and consumable supplies for dental offices. The company's Specialty Products & Technologies division focuses on dental implant systems, prosthetics, clear aligners, orthodontic products, and lab supplies, while the Equipment & Consumables segment produces digital imaging systems, endodontic systems, restorative materials, and infection prevention products. With a portfolio of over 30 trusted dental brands, Envista aims to partner with professionals to enhance patient care through innovative products, solutions, and technology. The company is dedicated to supporting dental professionals with quality products, integrated digital workflows, and comprehensive training programs for professional growth.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Sales Performance

Envista Holdings Corporation reported sales of $623.6 million for the first quarter of 2024, reflecting a slight decrease from the $627.2 million reported in the same quarter of 2023. Core sales in the quarter saw a modest increase of 0.4% compared to the corresponding quarter in the previous year.

Net Income

For the first quarter of 2024, Envista Holdings Corporation achieved a net income of $23.6 million, or $0.14 per diluted share. This represents a significant decline from the net income of $43.8 million, or $0.25 per diluted share, reported in the first quarter of 2023.

Adjusted Net Income

Envista Holdings Corporation's adjusted net income for the first quarter of 2024 was $45.8 million, or $0.26 per diluted share. This is a decrease from the adjusted net income of $67.8 million, or $0.38 per diluted share, recorded in the same period of the previous year.

Adjusted EBITDA

In the first quarter of 2024, Envista Holdings Corporation reported an adjusted EBITDA of $87.2 million. This is a decline from the adjusted EBITDA of $114.0 million reported in the first quarter of 2023, indicating a challenging quarter for the company.

CEO Commentary

Amir Aghdaei, Chief Executive Officer of Envista Holdings Corporation, acknowledged the challenging first quarter of 2024 but highlighted the company's focus on long-term investments to drive growth and profitability. He noted progress in the Spark business and the stabilization of the consumables business, while also emphasizing the strategic priorities for the remainder of the year.

Summarized from source with an LLMView Source

Key figures

-10.7%1Y
-49.2%3Y
-22.2%5Y

Performance

37.5%1Y
34.4%3Y
40.0%5Y

Volatility

Market cap

3681 M

Market cap (USD)

Daily traded volume (Shares)

508,618

Daily traded volume (Shares)

1 day high/low

21.44 / 20.36

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Fukuda Denshi KK
Fukuda Denshi KK Fukuda Denshi KK Valor: 761836
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%JPY 7,320.00
Nipro KK
Nipro KK Nipro KK Valor: 763952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%JPY 1,388.00
Kaken Seiyaku KK
Kaken Seiyaku KK Kaken Seiyaku KK Valor: 762167
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%JPY 4,438.00
Otsuka Holdings KK
Otsuka Holdings KK Otsuka Holdings KK Valor: 12027218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.53%JPY 8,952.00
Mochida Seiyaku KK
Mochida Seiyaku KK Mochida Seiyaku KK Valor: 762797
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.84%JPY 3,320.00
Interparfums Inc
Interparfums Inc Interparfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.78%USD 130.66
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%USD 597.49
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 57.10
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 332.24
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 390.14